to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis
Clinical trial NCT05162937 · COMPLETED
Trial details
- NCT number
- NCT05162937
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2021-07-30
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.